Zhaoke Ophthalmology
Shenzhen, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese ophthalmic company developing novel small molecule drugs and medical devices for prevalent eye diseases.
Ophthalmology
Technology Platform
Focuses on novel formulations and delivery systems for ophthalmic small molecules to improve bioavailability and duration of action.
Opportunities
Benefiting from China's rapidly aging population and increasing diagnosis rates for chronic eye diseases.
Risk Factors
Heavy reliance on the domestic market exposes it to pricing pressures and regulatory shifts in China's healthcare policy.
Competitive Landscape
Faces intense competition from global giants like Novartis and Regeneron, as well as numerous local generic manufacturers in China.